Light and shadows of the new therapies for haemophilia treatment in the COVID-19 era

Blood Transfus. 2021 Jan;19(1):73-76. doi: 10.2450/2020.0241-20. Epub 2020 Sep 18.
No abstract available

MeSH terms

  • Acetylgalactosamine / therapeutic use
  • Antibodies, Bispecific / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • COVID-19 / complications
  • COVID-19 / epidemiology
  • Disease Management
  • Hemophilia A / complications
  • Hemophilia A / therapy*
  • Humans
  • RNA, Small Interfering / therapeutic use

Substances

  • Antibodies, Bispecific
  • Antibodies, Monoclonal, Humanized
  • RNA, Small Interfering
  • fitusiran
  • concizumab
  • emicizumab
  • Acetylgalactosamine